Prices delayed by at least 15 minutes | Print


Oxford Biomedica PLC (OXB)

ORD 50P
Sell: 194p|Buy: 200p|Change: 0.80 (0.41%)

Open 

193.63p


Previous close 

197.2p


Trade high 

198p


Volume 

482


Year high 

474.50p


Year low 

164.29p


Dividend yield 

-


Market capitalisation 

£197.92 mn


P/E ratio 

20.62


ISIN 

GB00BDFBVT43


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment

Share price

Performance 27/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Oxford Biomedica PLC+ 1.34
FTSE All Share+ 0.04
More...

Company profile

Oxford BioMedica PLC is a player in the healthcare market in the United Kingdom. As a biopharmaceutical company, it focuses on the field of immunotherapy by managing a platform of technologies for designing gene-based medicines. The company's operating segments include the Platform segment consists of the revenue-generating bioprocessing and process development activities undertaken for third parties. Its Product segment consists of the clinical and preclinical development of in vivo and ex vivo gene and cell therapy products. The company derives the maximum revenue from the Platform segment. Its Platform includes LentiVector, LentiStable, TRiPSystem, SecNuc, Analytics, and others. Geographically, it generates the majority of its revenue from Europe.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
28/03/202409:33:50198208411.84
28/03/202409:10:151981019.80
28/03/202409:00:35196.3928247485.09
28/03/202408:41:2619835.94
28/03/202408:26:57193.631427.11

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.